Early and long-term effect of the treatment with pyridostigmine in patients with GMPPB-related congenital myasthenic syndrome.
Bobadilla-Quesada EJ, Natera-de Benito D, Carrera-García L, Ortez C, Exposito-Escudero J, Jimenez-Mallebrera C, Jou C, Codina A, Corbera J, Moya O, Saez V, Gonzalez-Quereda L, Gallano P, Colomer J, Cuadras D, Medina J, Yoldi ME, Nascimento A.
Bobadilla-Quesada EJ, et al. Among authors: corbera j.
Neuromuscul Disord. 2020 Sep;30(9):719-726. doi: 10.1016/j.nmd.2020.07.009. Epub 2020 Jul 24.
Neuromuscul Disord. 2020.
PMID: 32819792